Keyphrases
Clinical Adverse Events
100%
Nonclinical
100%
Clinical Risk
100%
Adverse Events
71%
Drug Withdrawal
71%
Clinical Observation
42%
Arrhythmia
28%
Non-inferiority Trial
28%
High Risk
28%
Approved Drugs
14%
Clinical Trials
14%
Diagnostic Test
14%
QT Prolongation
14%
Risk Assessment
14%
Human Trials
14%
Overall Risk
14%
Large Set
14%
Drug Program
14%
Bayesian Analysis
14%
Drug Development Program
14%
Statistical Framework
14%
Future Success
14%
Patient Safety Programs
14%
Risk Profile
14%
Hepatic Function
14%
Statistical Methods
14%
Hepatic Necrosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Clinical Study
25%
Heart Arrhythmia
25%
Drug Development
12%
Clinical Trial
12%
QT Prolongation
12%
Lufenuron
12%
Liver Necrosis
12%